To identify genes whose expression is modulated by TEAD2 in CD4 T and B cells, we examined TEAD2 knockdown (KD) and over-expression (OE) in cancer cell lines (n = 8, respectively) from the Library of Integrated Network-Based Cellular Signatures (LINCS) Program [41]. This evidence concerns the gene TEAD2 and cancer.